EMMA EMMAUS LIFE SCI

OTC
$0.07

EMMAUS LIFE SCI (EMMA) is expected to report earnings on November 12, 2026, after the market close.

EMMAUS LIFE SCI Reported Earnings
Friday, August 14, 2026 · 4:11 PM ET
Earnings Date
Nov 12
Thursday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About EMMAUS LIFE SCI

Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.